Post

See how Aurora Series powers plasma proteomics. Our latest Impact Portfolio brings together peer-reviewed evidence across population-scale cohorts, deep profiling, biomarker discovery and clinical validation, including 40,000+ samples analysed over 353 days. Download your copy: tinyurl.com/yjtdb8dm